Evidence map›Paper›PMID 30151598›Full record

ArticleWorld journal of urology2019

Prostate cancer navigation: initial experience and association with time to care.

Emily C Serrell, Moritz Hansen, Greg Mills, Andrew Perry, Tracy Robbins, Melanie Feinberg, Scot C Remick, Lisa Beaule, Matt Hayn, Tom Kinkead and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Emily C SerrellTufts University School of Medicine, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2531-5784
Moritz HansenTufts University School of Medicine, Boston, MA, USA.
Greg MillsDivision of Urology, Maine Medical Center, Portland, ME, USA.
Andrew PerryMaine Medical Center Cancer Institute, Scarborough, ME, USA.
Tracy RobbinsMaine Medical Center Cancer Institute, Scarborough, ME, USA.
Melanie FeinbergMaine Medical Center Cancer Institute, Scarborough, ME, USA.
Scot C RemickMaine Medical Center Cancer Institute, Scarborough, ME, USA.
Lisa BeauleTufts University School of Medicine, Boston, MA, USA.
Matt HaynTufts University School of Medicine, Boston, MA, USA.
Tom KinkeadTufts University School of Medicine, Boston, MA, USA.
Paul K J HanTufts University School of Medicine, Boston, MA, USA.
Jesse D SammonTufts University School of Medicine, Boston, MA, USA. jsammon79@gmail.com.
Tufts University · USMaine Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate factors associated with use of patient navigation in a prostate cancer population and identify whether navigation is associated with prolonged time to care. Cancer patient navigation has been shown to improve access to cancer screening, diagnosis, and treatment, but little is known about patient navigation in prostate cancer care.

methodsAll men diagnosed with localized prostate cancer between 2009 and 2015 were abstracted from the MaineHealth multi-specialty tumor registry. Regression analyses controlling for patient-, disease-, and system-level factors evaluated characteristics associated with navigation utilization. The association between navigation utilization, barriers to care, and longer time to treatment was assessed with Cox proportional hazards regression.

resultsOf the patient population (n = 1587), 85% of men were navigated. Navigation use was associated with earlier year of diagnosis, treatment by a high-volume urologist, and lower risk disease (p < 0.05). Treatment delay was associated with low-risk disease (vs: intermediate OR 0.62, 95% CI 0.46-0.85 and high OR 0.16, 95% CI 0.1-0.25) and receipt of navigation services (OR 1.65, 95% CI 1.12-2.45) but not distance to care, insurance, or treatment choice.

conclusionsWe observed that patients with low-risk prostate cancer were more likely to utilize navigation, but traditional barriers to care were not associated with utilization. Navigation was associated with longer time to treatment, which likely reflects clinically appropriate delays associated with greater shared decision making. Time to treatment may not be the ideal metric for evaluating navigation in prostate cancer; shared decision making, patient satisfaction, and psychosocial outcomes may be more appropriate.

Indexed as

HumansMaleMiddle AgedPatient NavigationProspective StudiesProstatic NeoplasmsRegistriesTime-to-TreatmentPatient navigationProstate cancerQuality improvementShared decision making

Identifiers

PMID30151598
OpenAlexW2889440945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.